Versant Capital Management, Inc Emergent Bio Solutions Inc. Transaction History
Versant Capital Management, Inc
- $454 Million
- Q4 2024
A detailed history of Versant Capital Management, Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 166 shares of EBS stock, worth $962. This represents 0.0% of its overall portfolio holdings.
Number of Shares
166
Previous 166
-0.0%
Holding current value
$962
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding EBS
# of Institutions
173Shares Held
36.8MCall Options Held
336KPut Options Held
203K-
Black Rock Inc. New York, NY3.84MShares$22.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$18.6 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.14MShares$12.4 Million0.01% of portfolio
-
State Street Corp Boston, MA1.96MShares$11.4 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.54MShares$8.93 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $289M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...